ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Jan 19, 2022 17:36 JST
Source: Eisai
Eisai Listed as a Global 100 Most Sustainable Corporation for the Sixth Time
Highest Ranked Global Pharmaceutical Company
TOKYO, Jan 19, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has been listed in the 2022 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corporate Knights, Inc. This marks Eisai's sixth inclusion on the list. Ranked 32nd, Eisai was the highest ranking company among global pharmaceutical companies.
The Global 100 evaluates the sustainability of approximately 6,900 of the world's major corporations based on various corporate initiatives in areas such as ESG (environment, society and governance). Since 2005, those companies ranking among the top 100 in the world have been announced each year. The Global 100 is based on up to 24 key performance indicators covering ESG initiatives, with the evaluations carried out based on data publicly disclosed in financial filings, integrated reports, or through other such channels. Eisai received high evaluation particularly on clean revenue and investment* and maintenance of work environment that ensures safety and health of employees.
Eisai's corporate philosophy is to give first thought to patients and their families, and increase the benefits that health care provides as well as address diverse healthcare needs worldwide. Based on this human health care (hhc) corporate philosophy, Eisai is striving to sustainably enhance corporate value by strengthening its ESG initiatives and increasing non-financial value.
*Sales revenue, R&D cost and investment for products such as medicines which are under equitable pricing strategies and included in the WHO Essentials Medicines Lists or used to treat any of in scope diseases, conditions and pathogens defined by the ATM Index Foundation.
Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120
Sectors: BioTech
Copyright ©2022 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
NEC and Juniper Networks Deploy Algeria Telecom's Nationwide 5G-Ready IP Metro Network
May 25, 2022 17:50 JST
Hitachi and Hitachi Astemo Developed Thin-type Inverter Technology for EVs That is More Compact and Energy Efficient
May 25, 2022 11:02 JST
DENSO, Honeywell Co-Develop E-Motor for Lilium's All-Electric Jet
May 25, 2022 10:01 JST
Toyota Announces May/June Production Suspension and June Production Plan
May 24, 2022 13:53 JST
NEC Provides AI-based Traffic Monitoring System with Fiber-optic Sensing Technology for NEXCO CENTRAL
May 24, 2022 11:27 JST
Mitsubishi Corporation signs Participation Agreement with Sempra Infrastructure, TotalEnergies, Mitsui for Carbon Sequestration Project in Louisiana
May 24, 2022 10:10 JST
Hitachi launches Lumada Inspection Insights and strengthens digital and green portfolio
May 24, 2022 09:16 JST
Project-Finance Agreement Signed for MC-Hokuden Hydro Power Alliance
May 23, 2022 11:15 JST
Mitsubishi Motors to Launch the All-New eK X EV in Japan
May 23, 2022 09:36 JST
NEC and Toyota Technical Development Develop Stable Wireless Control System for Cars and other Moving Objects in Factories
May 23, 2022 09:24 JST
MC and Morgenrot Enter into Capital and Business Alliance
May 20, 2022 20:19 JST
ROOKIE Racing and TOM'S SPIRIT Announce Team Setups for Super Taikyu Series Fuji 24 Hours Race
May 20, 2022 13:42 JST
MC and Kurashiki City Sign Regional Development Agreement
May 20, 2022 10:55 JST
BDO announces winners of the BDO ESG Awards 2022
May 19, 2022 22:20 JST
MHI-MS Introduces the New "MC" Flexo Folder Gluer: The Latest Innovation from the World's Leading Industrial Firm
May 18, 2022 20:36 JST
Lexus to Unveil All-New RX on June 1, 2022
May 18, 2022 19:38 JST
Fujitsu Signs Strategic Collaboration Agreement with AWS to Accelerate Digital Transformation in Finance and Retail Industry
May 18, 2022 14:51 JST
Yew Lee Pacific Group Berhad Launches Prospectus for ACE Market IPO
May 17, 2022 13:30 JST
Alba Signs Agreement with Mitsubishi Power & SEPCOIII as EPC Contractor for Block 4 in Power Station 5
May 17, 2022 12:26 JST
Fujitsu and RIKEN start joint research on next-generation IT drug discovery technology using the supercomputer Fugaku and simulation integrated AI
May 17, 2022 11:32 JST
More Latest Release >>
Related Release
Eisai Completes Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab for Early Alzheimer's Disease Under the Accelerated Approval Pathway
5/10/2022 11:23:00 AM JST
Eisai Initiates Preparation for New Drug Application, Based on the Results of an Investigator-Initiated Clinical Trial of Ultrahigh-Dose Mecobalamin for Amyotrophic Lateral Sclerosis in Japan
5/10/2022 11:00:00 AM JST
Eisai Announces Acquisition of Arteryex Shares (Making Arteryex a Subsidiary) to Strengthen and Rapidly Expand the Foundation of its Digital Solution Business
4/1/2022 2:05:00 PM JST
Eisai: Announcement About an Approval for Additional Indication of Jyseleca, JAK inhibitor
3/28/2022 10:38:00 PM JST
Eisai: Latest Findings on Lecanemab Presented at AD/PD 2022 Annual Meeting
3/22/2022 10:21:00 AM JST
Eisai: Economic Arrangements of Amendment to Alzheimer's Disease Treatment Collaboration Agreement with Biogen
3/15/2022 1:03:00 PM JST
Biogen and Eisai Amend Collaboration Agreements on Alzheimer's Disease Treatments
3/15/2022 12:00:00 PM JST
Eisai to Present New Lecanemab Data Exploring Distinct Mechanism of Action and Clinical Outcomes, Disease State (DSE) Symposium, and Other Pipeline Assets at the AD/PD 2022 Annual Meeting
3/11/2022 12:15:00 PM JST
Eisai Certified as the 2022 Health and Productivity Management Outstanding Organization (White 500)
3/9/2022 4:06:00 PM JST
LENVIMA in Combination with KEYTRUDA Approved In Taiwan for the Treatment of Patients with Advanced Endometrial Carcinoma
3/7/2022 1:50:00 PM JST
More Press release >>